Salud financiera de hoja de balance de Sartorius Stedim Biotech
Salud financiera controles de criterios 3/6
Sartorius Stedim Biotech tiene un patrimonio de accionistas total de €3.9B y una deuda total de €3.1B, lo que sitúa su ratio deuda-patrimonio en 79.5%. Sus activos y pasivos totales son €8.4B y €4.6B respectivamente. El BAIT de Sartorius Stedim Biotech es de €424.9M, por lo que su ratio de cobertura de intereses es de 3.1. Tiene efectivo e inversiones a corto plazo que ascienden a €727.7M.
Información clave
79.5%
Ratio deuda-patrimonio
€3.07b
Deuda
| Ratio de cobertura de intereses | 3.1x |
| Efectivo | €727.70m |
| Patrimonio | €3.87b |
| Total pasivo | €4.57b |
| Activos totales | €8.44b |
Actualizaciones recientes sobre salud financiera
Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?
Dec 01
Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 23Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly
May 25Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly
Feb 07Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet
Nov 09We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt
Jul 26Recent updates
Sartorius Stedim Biotech S.A. Just Missed EPS By 26%: Here's What Analysts Think Will Happen Next
Apr 21With A 26% Price Drop For Sartorius Stedim Biotech S.A. (EPA:DIM) You'll Still Get What You Pay For
Apr 20Weak Statutory Earnings May Not Tell The Whole Story For Sartorius Stedim Biotech (EPA:DIM)
Feb 19Sartorius Stedim Biotech S.A.'s (EPA:DIM) Popularity With Investors Is Clear
Dec 22Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?
Dec 01Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?
Nov 10Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Aug 23Sartorius Stedim Biotech (EPA:DIM) Seems To Use Debt Quite Sensibly
May 25Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Is Well Worth Watching
May 09Are Sartorius Stedim Biotech S.A. (EPA:DIM) Investors Paying Above The Intrinsic Value?
Apr 23Here's Why Sartorius Stedim Biotech (EPA:DIM) Can Manage Its Debt Responsibly
Feb 07Does Sartorius Stedim Biotech (EPA:DIM) Deserve A Spot On Your Watchlist?
Jan 20Sartorius Stedim Biotech (EPA:DIM) Has A Pretty Healthy Balance Sheet
Nov 09Here's Why We Think Sartorius Stedim Biotech (EPA:DIM) Might Deserve Your Attention Today
Oct 20Estimating The Fair Value Of Sartorius Stedim Biotech S.A. (EPA:DIM)
Oct 03We Think Sartorius Stedim Biotech (EPA:DIM) Can Stay On Top Of Its Debt
Jul 26Do Sartorius Stedim Biotech's (EPA:DIM) Earnings Warrant Your Attention?
Jul 09Is Sartorius Stedim Biotech S.A. (EPA:DIM) Expensive For A Reason? A Look At Its Intrinsic Value
Jun 21Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt
Apr 21Here's Why I Think Sartorius Stedim Biotech (EPA:DIM) Is An Interesting Stock
Apr 03We Like Sartorius Stedim Biotech's (EPA:DIM) Earnings For More Than Just Statutory Profit
Feb 24Does Sartorius Stedim Biotech (EPA:DIM) Have A Healthy Balance Sheet?
Dec 04Sartorius Stedim Biotech (EPA:DIM) Could Easily Take On More Debt
Aug 21Is Sartorius Stedim Biotech (EPA:DIM) Using Too Much Debt?
May 10Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo (€2.1B) de DIM superan a sus pasivos a corto plazo (€975.4M).
Pasivo a largo plazo: Los activos a corto plazo (€2.1B) de DIM no cubren sus pasivos a largo plazo (€3.6B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: La relación deuda neta-capital de DIM (60.6%) se considera alta.
Reducción de la deuda: El ratio deuda-patrimonio de DIM ha crecido de 8.7% a 79.5% en los últimos 5 años.
Cobertura de la deuda: La deuda de DIM está bien cubierta por el flujo de caja operativo (20.7%).
Cobertura de intereses: Los pagos de intereses de la deuda de DIM están bien cubiertos por el BAIT (3.1x cobertura).